These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38325652)
21. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations. Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207 [TBL] [Abstract][Full Text] [Related]
22. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis. Zhang X; Wu Y; Wang D BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695 [TBL] [Abstract][Full Text] [Related]
23. Pediatric Antibiotic Stewardship: Optimization of Vancomycin Therapy Based on Individual Pharmacokinetics. Kreitmeyr K; Pecar A; Mikolajczyk R; von Both U; Huebner J Pediatr Infect Dis J; 2021 Jun; 40(6):556-562. PubMed ID: 33956756 [TBL] [Abstract][Full Text] [Related]
24. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Song X; Han M Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144 [TBL] [Abstract][Full Text] [Related]
26. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354 [TBL] [Abstract][Full Text] [Related]
27. Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study. Lu H; Duan L; Yu Y; Li J; Shi L; Xue S; Zhang Q; Zhou Q; Zhu C; Shang E; Yan X; Tang L J Chemother; 2022 Nov; 34(7):446-458. PubMed ID: 35773225 [TBL] [Abstract][Full Text] [Related]
31. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program. Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687 [TBL] [Abstract][Full Text] [Related]
33. Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement. Olson J; Hersh AL; Sorensen J; Zobell J; Anderson C; Thorell EA J Pediatric Infect Dis Soc; 2020 Jul; 9(3):334-341. PubMed ID: 31344233 [TBL] [Abstract][Full Text] [Related]
34. Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial. Van Wynsberge G; Grootaert V; Buyle F; Van Praet J; Colman R; Moors I; Somers A; Veld DHI'; De Cock P; Trials; 2024 Feb; 25(1):126. PubMed ID: 38365814 [TBL] [Abstract][Full Text] [Related]
35. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques. Lewis SJ; Mueller BA J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685 [TBL] [Abstract][Full Text] [Related]
36. Individualized Vancomycin Dosing with Therapeutic Drug Monitoring and Pharmacokinetic Consultation Service: A Large-Scale Retrospective Observational Study. Kim SM; Lee HS; Hwang NY; Kim K; Park HD; Lee SY Drug Des Devel Ther; 2021; 15():423-440. PubMed ID: 33692613 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature. Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468 [TBL] [Abstract][Full Text] [Related]
38. Vancomycin therapeutic drug monitoring in paediatrics. Patel J; Lucas CJ; Ryan J; Jenkins M; Martin JH J Paediatr Child Health; 2020 Apr; 56(4):563-570. PubMed ID: 31721353 [TBL] [Abstract][Full Text] [Related]